COVID-19 activates a similar inflammatory response in the brain to Parkinson's disease, a University of Queensland-led study suggests.
Lead researcher Trent Woodruff, from the university's neuro-inflammation laboratory, said the findings illustrated a potential future risk for neurodegenerative conditions in people who had been infected with SARS-CoV-2, the virus that causes COVID-19.